Alvara Therapeutics Overview
- Year Founded
-
2026
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$651K
- Investors
-
2
Alvara Therapeutics General Information
Description
Developer of small-molecule medicines designed to treat chronic kidney disease. The company uses fragment-based drug discovery and structural biology to develop inhibitors of the Keap1-Nrf2 interaction, enabling the activation of antioxidant and anti-inflammatory proteins to help preserve kidney function.
Contact Information
Website
www.alvaratx.comCorporate Office
- Ole Maaløes Vej 3
- Copenhagen North
- 2200 Copenhagen
- Denmark
Corporate Office
- Ole Maaløes Vej 3
- Copenhagen North
- 2200 Copenhagen
- Denmark
Alvara Therapeutics Timeline
Alvara Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 16-Sep-2026 | $651K | Completed | Startup | ||
| 1. University Spin-Out | 10-Jul-2026 | Completed | Startup |
Alvara Therapeutics Signals
Alvara Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioInnovation Institute | Accelerator/Incubator | |||
| University of Copenhagen | University |
Alvara Therapeutics FAQs
-
When was Alvara Therapeutics founded?
Alvara Therapeutics was founded in 2026.
-
Where is Alvara Therapeutics headquartered?
Alvara Therapeutics is headquartered in Copenhagen, Denmark.
-
What is the size of Alvara Therapeutics?
Alvara Therapeutics has 3 total employees.
-
What industry is Alvara Therapeutics in?
Alvara Therapeutics’s primary industry is Drug Discovery.
-
Is Alvara Therapeutics a private or public company?
Alvara Therapeutics is a Private company.
-
What is Alvara Therapeutics’s current revenue?
The current revenue for Alvara Therapeutics is .
-
How much funding has Alvara Therapeutics raised over time?
Alvara Therapeutics has raised $651K.
-
Who are Alvara Therapeutics’s investors?
BioInnovation Institute and University of Copenhagen have invested in Alvara Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process